Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis

Journal of Human Hypertension

Volumn 28, Issue 1, 2014, Pages 18-24

  Chang, T I ^a   Flythe, J E ^b   Brunelli, S M ^b   Muntner, P ^c   Greene, T ^d   Cheung, A K ^d   Chertow, G M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure variability; Cardiovascular disease; End stage renal disease; Hemodialysis; Hypertension

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SYSTOLIC BLOOD PRESSURE; VISIT TO VISIT BLOOD PRESSURE VARIABILITY; ADOLESCENT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SYSTOLE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; SYSTOLE;

EID: 84889680096     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.49     Document Type: Article

References (34)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet 2002; 360(9349): 1903-1913.
2. Weiss JW, Johnson ES, Petrik A, Smith DH, Yang X, Thorp ML. Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis 2010; 56(6): 1062-1071.
3. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D et al. 'U' curve association of blood pressure and mortality in hemodialysis patients. Medical directors of dialysis clinic, inc. Kidney Int 1998; 54(2): 561-569.
4. Li Z, Lacson Jr E, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48(4): 606-615.
5. Chang TI, Friedman GD, Cheung AK, Greene T, Desai M, Chertow GM. Systolic blood pressure and mortality in prevalent haemodialysis patients in the hemo study. J Hum Hypertens 2011; 25(2): 98-105.
6. Mancia G. Blood pressure variability at normal and high blood pressure. Chest 1983; 83(2 Suppl): 317-320.
7. Rossignol P, Cridlig J, Lehert P, Kessler M, Zannad F. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis/novelty and significance. Hypertension 2012; 60(2): 339-346.
8. Brunelli SM, Thadhani RI, Lynch KE, Ankers ED, Joffe MM, Boston R et al. Association between long-term blood pressure variability and mortality among incident hemodialysis patients. Am J Kidney Dis 2008; 52(4): 716-726.
9. Brueren MM, Limpt PV, Schouten HJA, de Leeuw PW, van Ree JW. Is a series of blood pressure measurements by the general practitioner or the patient a reliable alternative to ambulatory blood pressure measurement? Am J Hypertens 1997; 10(8): 879-885.
10. Howard SC, Rothwell PM. Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke. Cerebrovasc Dis 2009; 28(4): 331-340.
11. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population. Hypertension 2011; 57(2): 160-166.
12. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. The Lancet 2010; 375(9718): 895-905.
13. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. The Lancet 2010; 375(9718): 938-948.
14. Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis. Hypertension 2008; 52(6): 1045-1050.
15. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21(12): 2251-2257.
16. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ et al. Longterm prognostic value of blood pressure variability in the general population. Hypertension 2007; 49(6): 1265-1270.
17. Farrell B, Godwin J, Richards S, Warlow C. The united kingdom transient ischaemic attack (uk-tia) aspirin trial: Final results. J Neurol Neurosurg Psychiatry 1991; 54(12): 1044-1054.
18. Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS et al. Design and statistical issues of the hemodialysis (hemo) study. Control Clin Trials 2000; 21(5): 502-525.
19. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347(25): 2010-2019.
20. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW et al. Comorbidity assessment using the index of coexistent diseases in a multicenter clinical trial. Kidney Int 2001; 60(4): 1498-1510.
21. Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23(3): 505-511.
22. Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Generalized linear models. In Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. Springer Science: New York, pp 291-303, 2005.
23. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8(5): 551-561.
24. Di Iorio B, Di Micco L, Torraca S, Sirico ML, Guastaferro P, Chiuchiolo L et al. Variability of blood pressure in dialysis patients: a new marker of cardiovascular risk. J Nephrol 2013; 26(1): 173-182.
25. Tozawa M, Iseki K, Yoshi S, Fukiyama K. Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease. Nephrol Dial Transplant 1999; 14(8): 1976-1981.
26. Kawai T, Ohishi M, Kamide K, Onishi M, Takeya Y, Tatara Y et al. The impact of visitto-visit variability in blood pressure on renal function. Hypertens Res 2011; 35(2): 239-243.
27. Asayama K, Kikuya M, Schutte R, Thijs L, Hosaka M, Satoh M et al. Home blood pressure variability as cardiovascular risk factor in the population of ohasama. Hypertension 2013; 61(1): 61-69.
28. Di Iorio B, Pota A, Sirico ML, Torraca S, Di Micco L, Rubino R et al. Blood pressure variability and outcomes in chronic kidney disease. Nephrol Dial Transplant 2012; 27(12): 4404-4410.
29. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the european lacidipine study on atherosclerosis/clinical perspective. Circulation 2012; 126(5): 569-578.
30. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18(10): 2758-2765.
31. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis. Lancet 2010; 375(9718): 906-915.
32. Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: A 5.5-year prospective analysis. Eur J Clin Invest 2012; 42(3): 245-253.
33. Okada H, Fukui M, Tanaka M, Matsumoto S, Mineoka Y, Nakanishi N et al. Visit-tovisit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes. Diabetes Care (e-pub ahead of print 22 January 2013).
34. Muntner P, Levitan EB, Joyce C, Holt E, Mann D, Oparil S et al. Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure. J Clin Hypertens 2013; 15(2): 112-117.